

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 8.61605376 |
| 2 | actin-myosin filament sliding (GO:0033275) | 8.61605376 |
| 3 | sarcomere organization (GO:0045214) | 7.02827222 |
| 4 | actin-mediated cell contraction (GO:0070252) | 6.90657496 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 6.39918946 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.26037269 |
| 7 | skeletal muscle contraction (GO:0003009) | 6.21815711 |
| 8 | plasma membrane repair (GO:0001778) | 6.06769441 |
| 9 | myofibril assembly (GO:0030239) | 5.66712612 |
| 10 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.54882328 |
| 11 | positive regulation of myoblast differentiation (GO:0045663) | 5.34508810 |
| 12 | cardiac myofibril assembly (GO:0055003) | 5.32136045 |
| 13 | muscle structure development (GO:0061061) | 5.22542133 |
| 14 | actin filament-based movement (GO:0030048) | 5.10458420 |
| 15 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.10273128 |
| 16 | negative regulation of protein localization to cell surface (GO:2000009) | 4.88111102 |
| 17 | skeletal muscle fiber development (GO:0048741) | 4.84646626 |
| 18 | striated muscle contraction (GO:0006941) | 4.82403410 |
| 19 | cardiac muscle cell development (GO:0055013) | 4.70815683 |
| 20 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.68935373 |
| 21 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 4.63408660 |
| 22 | multicellular organismal movement (GO:0050879) | 4.55962185 |
| 23 | musculoskeletal movement (GO:0050881) | 4.55962185 |
| 24 | striated muscle tissue development (GO:0014706) | 4.54731734 |
| 25 | skeletal muscle tissue regeneration (GO:0043403) | 4.49251157 |
| 26 | cardiac cell development (GO:0055006) | 4.42217811 |
| 27 | positive regulation of myotube differentiation (GO:0010831) | 4.34600316 |
| 28 | actomyosin structure organization (GO:0031032) | 4.32484533 |
| 29 | cardiac muscle contraction (GO:0060048) | 4.25405983 |
| 30 | neuromuscular synaptic transmission (GO:0007274) | 4.24851218 |
| 31 | myotube differentiation (GO:0014902) | 4.22828575 |
| 32 | heart process (GO:0003015) | 4.20728897 |
| 33 | heart contraction (GO:0060047) | 4.20728897 |
| 34 | muscle cell fate commitment (GO:0042693) | 4.17225054 |
| 35 | response to gravity (GO:0009629) | 4.07674971 |
| 36 | muscle tissue development (GO:0060537) | 4.03721031 |
| 37 | DNA deamination (GO:0045006) | 4.02743307 |
| 38 | myotube cell development (GO:0014904) | 4.02738572 |
| 39 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.01897566 |
| 40 | regulation of relaxation of muscle (GO:1901077) | 4.01730633 |
| 41 | tricarboxylic acid cycle (GO:0006099) | 4.01037753 |
| 42 | muscle adaptation (GO:0043500) | 3.99119708 |
| 43 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.95506061 |
| 44 | sequestering of actin monomers (GO:0042989) | 3.93613501 |
| 45 | membrane raft organization (GO:0031579) | 3.91881759 |
| 46 | striated muscle cell development (GO:0055002) | 3.87487245 |
| 47 | regulation of myoblast differentiation (GO:0045661) | 3.85605873 |
| 48 | response to activity (GO:0014823) | 3.85546316 |
| 49 | regulation of sarcomere organization (GO:0060297) | 3.81915494 |
| 50 | muscle fiber development (GO:0048747) | 3.75006994 |
| 51 | response to muscle activity (GO:0014850) | 3.74109722 |
| 52 | response to inactivity (GO:0014854) | 3.72826797 |
| 53 | muscle contraction (GO:0006936) | 3.71804329 |
| 54 | positive regulation of skeletal muscle tissue development (GO:0048643) | 3.68870259 |
| 55 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.68183574 |
| 56 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.68057858 |
| 57 | skeletal muscle adaptation (GO:0043501) | 3.66782731 |
| 58 | regulation of membrane repolarization (GO:0060306) | 3.66219047 |
| 59 | regulation of cell communication by electrical coupling (GO:0010649) | 3.56724912 |
| 60 | regulation of myotube differentiation (GO:0010830) | 3.56449230 |
| 61 | regulation of actin filament-based movement (GO:1903115) | 3.49736763 |
| 62 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.47174558 |
| 63 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.46477608 |
| 64 | oxidative phosphorylation (GO:0006119) | 3.45711754 |
| 65 | glycogen biosynthetic process (GO:0005978) | 3.45187871 |
| 66 | glucan biosynthetic process (GO:0009250) | 3.45187871 |
| 67 | striated muscle atrophy (GO:0014891) | 3.44600286 |
| 68 | muscle tissue morphogenesis (GO:0060415) | 3.44481390 |
| 69 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.44243467 |
| 70 | regulation of muscle system process (GO:0090257) | 3.39560704 |
| 71 | muscle cell development (GO:0055001) | 3.39426494 |
| 72 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.37135053 |
| 73 | positive regulation of striated muscle cell differentiation (GO:0051155) | 3.33433921 |
| 74 | muscle system process (GO:0003012) | 3.32997193 |
| 75 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.27394089 |
| 76 | cytidine metabolic process (GO:0046087) | 3.25605998 |
| 77 | cytidine catabolic process (GO:0006216) | 3.25605998 |
| 78 | cytidine deamination (GO:0009972) | 3.25605998 |
| 79 | muscle cell cellular homeostasis (GO:0046716) | 3.25503074 |
| 80 | skeletal muscle cell differentiation (GO:0035914) | 3.25149438 |
| 81 | carnitine shuttle (GO:0006853) | 3.24891805 |
| 82 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.23972101 |
| 83 | regulation of muscle contraction (GO:0006937) | 3.23307741 |
| 84 | IMP metabolic process (GO:0046040) | 3.20691703 |
| 85 | regulation of striated muscle contraction (GO:0006942) | 3.20635096 |
| 86 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.19953196 |
| 87 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.17924447 |
| 88 | cellular response to zinc ion (GO:0071294) | 3.16431169 |
| 89 | negative regulation of potassium ion transport (GO:0043267) | 3.14317512 |
| 90 | neuromuscular junction development (GO:0007528) | 3.14116554 |
| 91 | regulation of skeletal muscle fiber development (GO:0048742) | 3.09875476 |
| 92 | positive regulation of muscle cell differentiation (GO:0051149) | 3.08653889 |
| 93 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.08177265 |
| 94 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.00166157 |
| 95 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.96864818 |
| 96 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.96864818 |
| 97 | regulation of coenzyme metabolic process (GO:0051196) | 2.96384199 |
| 98 | regulation of cofactor metabolic process (GO:0051193) | 2.96384199 |
| 99 | regulation of ATP catabolic process (GO:1903289) | 2.92770152 |
| 100 | regulation of ATPase activity (GO:0043462) | 2.92770152 |
| 101 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.89707562 |
| 102 | creatine metabolic process (GO:0006600) | 2.88254658 |
| 103 | mitochondrial fusion (GO:0008053) | 2.85207175 |
| 104 | cellular response to dexamethasone stimulus (GO:0071549) | 2.84476644 |
| 105 | negative regulation of monooxygenase activity (GO:0032769) | 2.78279534 |
| 106 | adult heart development (GO:0007512) | 2.78136619 |
| 107 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.77761126 |
| 108 | IMP biosynthetic process (GO:0006188) | 2.77409512 |
| 109 | muscle organ morphogenesis (GO:0048644) | 2.77292941 |
| 110 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.74966117 |
| 111 | striated muscle adaptation (GO:0014888) | 2.74388889 |
| 112 | cardiac muscle hypertrophy (GO:0003300) | 2.73816411 |
| 113 | negative regulation of cell size (GO:0045792) | 2.71671598 |
| 114 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.71669237 |
| 115 | myoblast fusion (GO:0007520) | 2.70979296 |
| 116 | glycogen catabolic process (GO:0005980) | 2.70270330 |
| 117 | heart trabecula formation (GO:0060347) | 2.70181030 |
| 118 | transcription from mitochondrial promoter (GO:0006390) | 2.69239215 |
| 119 | muscle atrophy (GO:0014889) | 2.68343818 |
| 120 | striated muscle hypertrophy (GO:0014897) | 2.66151762 |
| 121 | skeletal muscle tissue development (GO:0007519) | 2.57450954 |
| 122 | apoptotic process involved in morphogenesis (GO:0060561) | 2.56824331 |
| 123 | ventricular cardiac muscle cell development (GO:0055015) | 2.55887980 |
| 124 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.53943513 |
| 125 | ATP synthesis coupled proton transport (GO:0015986) | 2.53943513 |
| 126 | membrane tubulation (GO:0097320) | 2.53467737 |
| 127 | epithelial cell-cell adhesion (GO:0090136) | 2.51438603 |
| 128 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.50454990 |
| 129 | syncytium formation (GO:0006949) | 2.48844969 |
| 130 | muscle hypertrophy (GO:0014896) | 2.48718169 |
| 131 | muscle organ development (GO:0007517) | 2.47189074 |
| 132 | fatty acid transmembrane transport (GO:1902001) | 2.46823486 |
| 133 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.45939036 |
| 134 | glucan catabolic process (GO:0009251) | 2.44453027 |
| 135 | neutrophil activation involved in immune response (GO:0002283) | 2.44035854 |
| 136 | cellular polysaccharide catabolic process (GO:0044247) | 2.43948061 |
| 137 | negative regulation of muscle hypertrophy (GO:0014741) | 2.43441087 |
| 138 | regulation of protein heterodimerization activity (GO:0043497) | 2.41770421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.87487164 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.86729152 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.12991985 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.30623301 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 3.11885660 |
| 6 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.99579553 |
| 7 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.84172429 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.45818391 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.42962018 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.38635059 |
| 11 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 2.33898035 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.32825869 |
| 13 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.25405673 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.05153274 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 1.94312817 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.91125474 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91088061 |
| 18 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.88109552 |
| 19 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.85067500 |
| 20 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.84795652 |
| 21 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.83765995 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83645106 |
| 23 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.81919287 |
| 24 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.75611730 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.74494819 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.73347833 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72030923 |
| 28 | CJUN_26792858_Chip-Seq_BT549_Human | 1.71187111 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.70971376 |
| 30 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.70571789 |
| 31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.69548417 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.68346687 |
| 33 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.65158725 |
| 34 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.63549300 |
| 35 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.63406220 |
| 36 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.63013638 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62629435 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61536972 |
| 39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.61328357 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60575117 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60490344 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.59959062 |
| 43 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.57708844 |
| 44 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.57708844 |
| 45 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.56318492 |
| 46 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.55961673 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.55504760 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54060714 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.53043008 |
| 50 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.49634993 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.48467368 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48338731 |
| 53 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.46889912 |
| 54 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46325155 |
| 55 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.46157452 |
| 56 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45194445 |
| 57 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44952838 |
| 58 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.44933222 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44885321 |
| 60 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.44884545 |
| 61 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.43700704 |
| 62 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.43531466 |
| 63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.42412768 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41438556 |
| 65 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38324054 |
| 66 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37608184 |
| 67 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.35858757 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35208254 |
| 69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.34470155 |
| 70 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.33710204 |
| 71 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.33616054 |
| 72 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33423761 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32651602 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32327033 |
| 75 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.31802806 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31730127 |
| 77 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29468336 |
| 78 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.28997691 |
| 79 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.28793197 |
| 80 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27398413 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26842799 |
| 82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26199570 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26193896 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26193896 |
| 85 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.26059880 |
| 86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25848878 |
| 87 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.25713906 |
| 88 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25465943 |
| 89 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.25139285 |
| 90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.24637545 |
| 91 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23832990 |
| 92 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23579170 |
| 93 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.23246984 |
| 94 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.23235959 |
| 95 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.22473042 |
| 96 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.21821902 |
| 97 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.19555253 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19301137 |
| 99 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.17297021 |
| 100 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.17070764 |
| 101 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.16232520 |
| 102 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.16226264 |
| 103 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.16016042 |
| 104 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.15948599 |
| 105 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.15102481 |
| 106 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13844618 |
| 107 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13328154 |
| 108 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13076926 |
| 109 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12865060 |
| 110 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11417816 |
| 111 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.11284174 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11270507 |
| 113 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11072889 |
| 114 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.11050414 |
| 115 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10885554 |
| 116 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10350614 |
| 117 | MAF_26560356_Chip-Seq_TH2_Human | 1.10034740 |
| 118 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.09231260 |
| 119 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.08980296 |
| 120 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.08950227 |
| 121 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.08913694 |
| 122 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.08846378 |
| 123 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08398465 |
| 124 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.06952687 |
| 125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.06503946 |
| 126 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.06351033 |
| 127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06068761 |
| 128 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05586505 |
| 129 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04290037 |
| 130 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.03610189 |
| 131 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03394318 |
| 132 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.02999190 |
| 133 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02992151 |
| 134 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02339827 |
| 135 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01728486 |
| 136 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.01634457 |
| 137 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.00195623 |
| 138 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00159007 |
| 139 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00099161 |
| 140 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.99848151 |
| 141 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99751833 |
| 142 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.99418998 |
| 143 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.98754843 |
| 144 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98524828 |
| 145 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98279562 |
| 146 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.98102023 |
| 147 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98094778 |
| 148 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97836177 |
| 149 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.97571517 |
| 150 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97244024 |
| 151 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96812416 |
| 152 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.96588767 |
| 153 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96481871 |
| 154 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.95915867 |
| 155 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.94442722 |
| 156 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93545962 |
| 157 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93506447 |
| 158 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93397126 |
| 159 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92792735 |
| 160 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92567376 |
| 161 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92118383 |
| 162 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.91941425 |
| 163 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.91006142 |
| 164 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.89209083 |
| 165 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.87135243 |
| 166 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86906659 |
| 167 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.86906659 |
| 168 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.86699281 |
| 169 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.86057032 |
| 170 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.85802745 |
| 171 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85312220 |
| 172 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84506619 |
| 173 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.84461271 |
| 174 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.83972788 |
| 175 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.82786065 |
| 176 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.82414430 |
| 177 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.81317123 |
| 178 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81182751 |
| 179 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.80725290 |
| 180 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.80115912 |
| 181 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79989152 |
| 182 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76576537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 5.10443527 |
| 2 | MP0000749_muscle_degeneration | 5.09230114 |
| 3 | MP0003646_muscle_fatigue | 4.75747795 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 4.36910724 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.86752906 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 3.76507707 |
| 7 | MP0000750_abnormal_muscle_regeneration | 3.72274544 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.34969238 |
| 9 | MP0002106_abnormal_muscle_physiology | 3.22734981 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.13853705 |
| 11 | MP0002269_muscular_atrophy | 3.05117401 |
| 12 | MP0005330_cardiomyopathy | 3.00189677 |
| 13 | MP0000747_muscle_weakness | 2.97959960 |
| 14 | MP0000759_abnormal_skeletal_muscle | 2.74588650 |
| 15 | MP0005369_muscle_phenotype | 2.57874930 |
| 16 | MP0004215_abnormal_myocardial_fiber | 2.56674421 |
| 17 | MP0004270_analgesia | 2.56492423 |
| 18 | MP0000733_abnormal_muscle_development | 2.19732711 |
| 19 | MP0004233_abnormal_muscle_weight | 2.14696724 |
| 20 | MP0005620_abnormal_muscle_contractility | 2.14664235 |
| 21 | MP0003828_pulmonary_edema | 2.01424952 |
| 22 | MP0010630_abnormal_cardiac_muscle | 1.99459022 |
| 23 | MP0002972_abnormal_cardiac_muscle | 1.96777759 |
| 24 | MP0003950_abnormal_plasma_membrane | 1.77243077 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.76672376 |
| 26 | MP0004130_abnormal_muscle_cell | 1.76100132 |
| 27 | MP0003137_abnormal_impulse_conducting | 1.66937792 |
| 28 | MP0002332_abnormal_exercise_endurance | 1.64582232 |
| 29 | MP0001544_abnormal_cardiovascular_syste | 1.64206627 |
| 30 | MP0005385_cardiovascular_system_phenoty | 1.64206627 |
| 31 | MP0001542_abnormal_bone_strength | 1.63761987 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.55391719 |
| 33 | MP0000343_altered_response_to | 1.52829161 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.51641653 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.51534536 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.44751901 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.43984783 |
| 38 | MP0003221_abnormal_cardiomyocyte_apopto | 1.43003841 |
| 39 | MP0000372_irregular_coat_pigmentation | 1.40262861 |
| 40 | MP0001299_abnormal_eye_distance/ | 1.33404642 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.25699718 |
| 42 | MP0004484_altered_response_of | 1.20722851 |
| 43 | MP0003279_aneurysm | 1.18576192 |
| 44 | MP0003045_fibrosis | 1.17553014 |
| 45 | MP0006138_congestive_heart_failure | 1.16228609 |
| 46 | MP0010030_abnormal_orbit_morphology | 1.11777873 |
| 47 | MP0003567_abnormal_fetal_cardiomyocyte | 1.10812677 |
| 48 | MP0008438_abnormal_cutaneous_collagen | 1.10447694 |
| 49 | MP0002127_abnormal_cardiovascular_syste | 1.04068289 |
| 50 | MP0001661_extended_life_span | 1.01731028 |
| 51 | MP0005266_abnormal_metabolism | 1.01440751 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.01321474 |
| 53 | MP0004510_myositis | 0.99819685 |
| 54 | MP0005171_absent_coat_pigmentation | 0.98232811 |
| 55 | MP0005058_abnormal_lysosome_morphology | 0.98005015 |
| 56 | MP0001853_heart_inflammation | 0.91701410 |
| 57 | MP0010094_abnormal_chromosome_stability | 0.91005064 |
| 58 | MP0004957_abnormal_blastocyst_morpholog | 0.86858106 |
| 59 | MP0005360_urolithiasis | 0.86792068 |
| 60 | MP0000266_abnormal_heart_morphology | 0.85693812 |
| 61 | MP0000371_diluted_coat_color | 0.83936064 |
| 62 | MP0003959_abnormal_lean_body | 0.83000306 |
| 63 | MP0001346_abnormal_lacrimal_gland | 0.82721599 |
| 64 | MP0008057_abnormal_DNA_replication | 0.80657105 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 0.80438572 |
| 66 | MP0002396_abnormal_hematopoietic_system | 0.78794510 |
| 67 | MP0003077_abnormal_cell_cycle | 0.78105418 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 0.76853374 |
| 69 | MP0005666_abnormal_adipose_tissue | 0.76295249 |
| 70 | MP0004272_abnormal_basement_membrane | 0.75892155 |
| 71 | MP0008007_abnormal_cellular_replicative | 0.75694940 |
| 72 | MP0009278_abnormal_bone_marrow | 0.75462288 |
| 73 | MP0004858_abnormal_nervous_system | 0.74779727 |
| 74 | MP0000767_abnormal_smooth_muscle | 0.74339297 |
| 75 | MP0002148_abnormal_hypersensitivity_rea | 0.74295654 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 0.74225126 |
| 77 | MP0002234_abnormal_pharynx_morphology | 0.72474651 |
| 78 | MP0005023_abnormal_wound_healing | 0.72430075 |
| 79 | MP0000762_abnormal_tongue_morphology | 0.72093133 |
| 80 | MP0005464_abnormal_platelet_physiology | 0.71762627 |
| 81 | MP0003436_decreased_susceptibility_to | 0.71749086 |
| 82 | MP0001958_emphysema | 0.71639966 |
| 83 | MP0004085_abnormal_heartbeat | 0.71516272 |
| 84 | MP0006082_CNS_inflammation | 0.70985465 |
| 85 | MP0001545_abnormal_hematopoietic_system | 0.68187094 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 0.68187094 |
| 87 | MP0002405_respiratory_system_inflammati | 0.68134050 |
| 88 | MP0003763_abnormal_thymus_physiology | 0.67563942 |
| 89 | MP0000003_abnormal_adipose_tissue | 0.67323129 |
| 90 | MP0000858_altered_metastatic_potential | 0.66062378 |
| 91 | MP0002896_abnormal_bone_mineralization | 0.66023764 |
| 92 | MP0002128_abnormal_blood_circulation | 0.64496627 |
| 93 | MP0003111_abnormal_nucleus_morphology | 0.64005660 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.63893688 |
| 95 | MP0005165_increased_susceptibility_to | 0.63489654 |
| 96 | MP0005671_abnormal_response_to | 0.62709771 |
| 97 | MP0002114_abnormal_axial_skeleton | 0.62532531 |
| 98 | MP0004883_abnormal_blood_vessel | 0.62015124 |
| 99 | MP0002734_abnormal_mechanical_nocicepti | 0.61107594 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.61058121 |
| 101 | MP0001835_abnormal_antigen_presentation | 0.58313090 |
| 102 | MP0005075_abnormal_melanosome_morpholog | 0.57082660 |
| 103 | MP0003191_abnormal_cellular_cholesterol | 0.55285622 |
| 104 | MP0003172_abnormal_lysosome_physiology | 0.55264877 |
| 105 | MP0005623_abnormal_meninges_morphology | 0.53541482 |
| 106 | MP0002019_abnormal_tumor_incidence | 0.52636811 |
| 107 | MP0002722_abnormal_immune_system | 0.52136101 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.52062360 |
| 109 | MP0002933_joint_inflammation | 0.52016506 |
| 110 | MP0008770_decreased_survivor_rate | 0.51865932 |
| 111 | MP0003806_abnormal_nucleotide_metabolis | 0.51713728 |
| 112 | MP0005174_abnormal_tail_pigmentation | 0.51431691 |
| 113 | MP0002971_abnormal_brown_adipose | 0.51123491 |
| 114 | MP0005595_abnormal_vascular_smooth | 0.51007158 |
| 115 | MP0002168_other_aberrant_phenotype | 0.50935905 |
| 116 | MP0000689_abnormal_spleen_morphology | 0.50620045 |
| 117 | MP0000313_abnormal_cell_death | 0.50360007 |
| 118 | MP0002075_abnormal_coat/hair_pigmentati | 0.49333026 |
| 119 | MP0009785_altered_susceptibility_to | 0.49274191 |
| 120 | MP0009250_abnormal_appendicular_skeleto | 0.49232376 |
| 121 | MP0005000_abnormal_immune_tolerance | 0.49150648 |
| 122 | MP0002398_abnormal_bone_marrow | 0.49054670 |
| 123 | MP0003693_abnormal_embryo_hatching | 0.48840638 |
| 124 | MP0005451_abnormal_body_composition | 0.48387222 |
| 125 | MP0005275_abnormal_skin_tensile | 0.47037927 |
| 126 | MP0002089_abnormal_postnatal_growth/wei | 0.40424064 |
| 127 | MP0002249_abnormal_larynx_morphology | 0.39577581 |
| 128 | MP0002822_catalepsy | 0.39434155 |
| 129 | MP0004134_abnormal_chest_morphology | 0.39316772 |
| 130 | MP0005452_abnormal_adipose_tissue | 0.36663881 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.35666472 |
| 132 | MP0003091_abnormal_cell_migration | 0.35527852 |
| 133 | MP0002184_abnormal_innervation | 0.35504314 |
| 134 | MP0004142_abnormal_muscle_tone | 0.33640423 |
| 135 | MP0000230_abnormal_systemic_arterial | 0.32672034 |
| 136 | MP0001986_abnormal_taste_sensitivity | 0.32610444 |
| 137 | MP0005375_adipose_tissue_phenotype | 0.31270260 |
| 138 | MP0008789_abnormal_olfactory_epithelium | 0.31181362 |
| 139 | MP0005376_homeostasis/metabolism_phenot | 0.30940502 |
| 140 | * MP0001943_abnormal_respiration | 0.28497801 |
| 141 | MP0005319_abnormal_enzyme/_coenzyme | 0.27939399 |
| 142 | MP0003879_abnormal_hair_cell | 0.26626271 |
| 143 | MP0002932_abnormal_joint_morphology | 0.23903541 |
| 144 | MP0006054_spinal_hemorrhage | 0.21617027 |
| 145 | MP0002113_abnormal_skeleton_development | 0.21494225 |
| 146 | MP0003385_abnormal_body_wall | 0.21058078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.95925646 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 6.92069558 |
| 3 | Nemaline bodies (HP:0003798) | 6.17603128 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 5.94884060 |
| 5 | Exercise-induced myalgia (HP:0003738) | 5.83409315 |
| 6 | Muscle fiber splitting (HP:0003555) | 5.62453719 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 5.40537262 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 5.27308895 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.16716301 |
| 10 | Difficulty running (HP:0009046) | 5.00537621 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 4.76261258 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 4.75683160 |
| 13 | Increased connective tissue (HP:0009025) | 4.58225882 |
| 14 | Sudden death (HP:0001699) | 4.53411653 |
| 15 | EMG: myopathic abnormalities (HP:0003458) | 4.51370709 |
| 16 | Distal arthrogryposis (HP:0005684) | 4.51071630 |
| 17 | Difficulty climbing stairs (HP:0003551) | 4.48930466 |
| 18 | * Type 2 muscle fiber atrophy (HP:0003554) | 4.11805543 |
| 19 | Ulnar deviation of the wrist (HP:0003049) | 4.09624790 |
| 20 | Ventricular tachycardia (HP:0004756) | 3.99249805 |
| 21 | Myopathic facies (HP:0002058) | 3.97305153 |
| 22 | Fetal akinesia sequence (HP:0001989) | 3.97039278 |
| 23 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.92955231 |
| 24 | Subaortic stenosis (HP:0001682) | 3.92955231 |
| 25 | * Muscle fiber atrophy (HP:0100295) | 3.88139397 |
| 26 | * Fatigable weakness (HP:0003473) | 3.85722829 |
| 27 | * Abnormality of the neuromuscular junction (HP:0003398) | 3.85722829 |
| 28 | Myoglobinuria (HP:0002913) | 3.83182527 |
| 29 | Myotonia (HP:0002486) | 3.78669862 |
| 30 | * Malignant hyperthermia (HP:0002047) | 3.77721633 |
| 31 | Round ear (HP:0100830) | 3.74105020 |
| 32 | Neck muscle weakness (HP:0000467) | 3.71489775 |
| 33 | Asymmetric septal hypertrophy (HP:0001670) | 3.71412283 |
| 34 | Rhabdomyolysis (HP:0003201) | 3.37000325 |
| 35 | * Weak cry (HP:0001612) | 3.36382139 |
| 36 | Bulbar palsy (HP:0001283) | 3.31615943 |
| 37 | Lipoatrophy (HP:0100578) | 3.31010678 |
| 38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.28177053 |
| 39 | * Gowers sign (HP:0003391) | 3.24084460 |
| 40 | Aplasia of the musculature (HP:0100854) | 3.17962620 |
| 41 | Calcaneovalgus deformity (HP:0001848) | 3.13128849 |
| 42 | Muscle stiffness (HP:0003552) | 3.07072324 |
| 43 | * Pterygium (HP:0001059) | 3.06827588 |
| 44 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.04008727 |
| 45 | * Popliteal pterygium (HP:0009756) | 2.95034504 |
| 46 | * Easy fatigability (HP:0003388) | 2.94543411 |
| 47 | Generalized muscle weakness (HP:0003324) | 2.94378975 |
| 48 | Atrial fibrillation (HP:0005110) | 2.93652794 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.90406312 |
| 50 | Increased variability in muscle fiber diameter (HP:0003557) | 2.89824876 |
| 51 | Distal lower limb amyotrophy (HP:0008944) | 2.88577426 |
| 52 | EMG: neuropathic changes (HP:0003445) | 2.85287281 |
| 53 | * Amniotic constriction ring (HP:0009775) | 2.79925887 |
| 54 | * Abnormality of placental membranes (HP:0011409) | 2.79925887 |
| 55 | Deformed tarsal bones (HP:0008119) | 2.77879778 |
| 56 | Rimmed vacuoles (HP:0003805) | 2.74685566 |
| 57 | Primary atrial arrhythmia (HP:0001692) | 2.74207067 |
| 58 | Supraventricular tachycardia (HP:0004755) | 2.70906874 |
| 59 | Dilated cardiomyopathy (HP:0001644) | 2.69653836 |
| 60 | Areflexia of lower limbs (HP:0002522) | 2.64783387 |
| 61 | Supraventricular arrhythmia (HP:0005115) | 2.63687214 |
| 62 | Limb-girdle muscle atrophy (HP:0003797) | 2.62761511 |
| 63 | Right ventricular cardiomyopathy (HP:0011663) | 2.59370960 |
| 64 | Long clavicles (HP:0000890) | 2.54712605 |
| 65 | Absent phalangeal crease (HP:0006109) | 2.53973026 |
| 66 | Palpitations (HP:0001962) | 2.48136098 |
| 67 | Progressive muscle weakness (HP:0003323) | 2.46747774 |
| 68 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.40458464 |
| 69 | Scapular winging (HP:0003691) | 2.37046541 |
| 70 | Frequent falls (HP:0002359) | 2.29779605 |
| 71 | Testicular atrophy (HP:0000029) | 2.22006187 |
| 72 | Akinesia (HP:0002304) | 2.15536431 |
| 73 | * Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.10882400 |
| 74 | Muscular dystrophy (HP:0003560) | 2.10602845 |
| 75 | Metatarsus adductus (HP:0001840) | 2.09529845 |
| 76 | Facial diplegia (HP:0001349) | 2.08909428 |
| 77 | Ventricular arrhythmia (HP:0004308) | 2.05234853 |
| 78 | Hip contracture (HP:0003273) | 2.04897497 |
| 79 | * Cystic hygroma (HP:0000476) | 2.03308958 |
| 80 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.00850013 |
| 81 | Abnormality of the calcaneus (HP:0008364) | 2.00102166 |
| 82 | Abnormal finger flexion creases (HP:0006143) | 1.97750944 |
| 83 | Waddling gait (HP:0002515) | 1.97649425 |
| 84 | Spinal rigidity (HP:0003306) | 1.97129372 |
| 85 | Hypoplastic heart (HP:0001961) | 1.93328422 |
| 86 | Proximal amyotrophy (HP:0007126) | 1.92116116 |
| 87 | * Thin ribs (HP:0000883) | 1.91436552 |
| 88 | Limited hip movement (HP:0008800) | 1.90987148 |
| 89 | Bundle branch block (HP:0011710) | 1.89315559 |
| 90 | Lower limb amyotrophy (HP:0007210) | 1.87778320 |
| 91 | Abnormal atrioventricular conduction (HP:0005150) | 1.85185656 |
| 92 | * Generalized amyotrophy (HP:0003700) | 1.84095764 |
| 93 | Slender build (HP:0001533) | 1.82005333 |
| 94 | Poor suck (HP:0002033) | 1.81558421 |
| 95 | * Nonprogressive disorder (HP:0003680) | 1.81150995 |
| 96 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.79188068 |
| 97 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.79188068 |
| 98 | Limb-girdle muscle weakness (HP:0003325) | 1.76983104 |
| 99 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.76392641 |
| 100 | Trismus (HP:0000211) | 1.75873512 |
| 101 | Breech presentation (HP:0001623) | 1.74064503 |
| 102 | Abnormality of the foot musculature (HP:0001436) | 1.73793549 |
| 103 | Heart block (HP:0012722) | 1.72655129 |
| 104 | Pelvic girdle muscle weakness (HP:0003749) | 1.72121160 |
| 105 | Diminished movement (HP:0002374) | 1.71972302 |
| 106 | Atrioventricular block (HP:0001678) | 1.71723017 |
| 107 | * Arthrogryposis multiplex congenita (HP:0002804) | 1.70615636 |
| 108 | Foot dorsiflexor weakness (HP:0009027) | 1.70105909 |
| 109 | Multiple enchondromatosis (HP:0005701) | 1.67951392 |
| 110 | Aortic aneurysm (HP:0004942) | 1.67728260 |
| 111 | Delayed gross motor development (HP:0002194) | 1.67563284 |
| 112 | Hypoplastic ischia (HP:0003175) | 1.65679579 |
| 113 | * Abnormalities of placenta or umbilical cord (HP:0001194) | 1.64262926 |
| 114 | Increased density of long bones (HP:0006392) | 1.61000105 |
| 115 | * Webbed neck (HP:0000465) | 1.59476340 |
| 116 | Left ventricular hypertrophy (HP:0001712) | 1.54186244 |
| 117 | Protrusio acetabuli (HP:0003179) | 1.49370529 |
| 118 | Infantile muscular hypotonia (HP:0008947) | 1.40685653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.19492119 |
| 2 | OBSCN | 4.66444994 |
| 3 | MUSK | 4.46522235 |
| 4 | TRIB3 | 2.95666972 |
| 5 | PHKG2 | 2.87451478 |
| 6 | PHKG1 | 2.87451478 |
| 7 | MOS | 2.54139589 |
| 8 | NEK1 | 2.25397522 |
| 9 | PDK3 | 2.16993180 |
| 10 | PDK4 | 2.16993180 |
| 11 | PKN2 | 2.12713015 |
| 12 | CCNB1 | 2.08183457 |
| 13 | PIM2 | 2.02470596 |
| 14 | PIK3CG | 2.00350444 |
| 15 | KDR | 1.89457213 |
| 16 | NME2 | 1.89009412 |
| 17 | MAPKAPK3 | 1.84102355 |
| 18 | MYLK | 1.50032386 |
| 19 | MAP4K1 | 1.48096677 |
| 20 | MAP3K11 | 1.43387108 |
| 21 | PDK2 | 1.40785346 |
| 22 | ILK | 1.39434902 |
| 23 | TRPM7 | 1.34361970 |
| 24 | TGFBR2 | 1.32305499 |
| 25 | DMPK | 1.32050941 |
| 26 | MAP2K3 | 1.32008499 |
| 27 | PINK1 | 1.30002713 |
| 28 | ICK | 1.25986860 |
| 29 | NEK9 | 1.22873800 |
| 30 | NME1 | 1.18754895 |
| 31 | STK24 | 1.17196119 |
| 32 | MATK | 1.13743023 |
| 33 | MAP3K12 | 1.13374387 |
| 34 | PAK4 | 1.08056976 |
| 35 | TESK2 | 1.06136239 |
| 36 | CDK8 | 1.02824302 |
| 37 | MAP2K1 | 1.01205838 |
| 38 | GRK7 | 1.00257220 |
| 39 | LMTK2 | 0.98547922 |
| 40 | KIT | 0.96904274 |
| 41 | TAOK2 | 0.96744636 |
| 42 | MAPK12 | 0.95499179 |
| 43 | BCKDK | 0.93071897 |
| 44 | MAPK11 | 0.87077072 |
| 45 | BMX | 0.85052442 |
| 46 | BLK | 0.84460479 |
| 47 | LRRK2 | 0.83175417 |
| 48 | BUB1 | 0.81550057 |
| 49 | STK10 | 0.80338122 |
| 50 | RPS6KB2 | 0.78344234 |
| 51 | ERN1 | 0.78301391 |
| 52 | EEF2K | 0.73430588 |
| 53 | CAMK2G | 0.72441892 |
| 54 | LIMK1 | 0.71755122 |
| 55 | RIPK1 | 0.70581293 |
| 56 | MAP3K10 | 0.68771155 |
| 57 | MAPK7 | 0.67538965 |
| 58 | STK16 | 0.66282023 |
| 59 | CDK12 | 0.66126637 |
| 60 | WEE1 | 0.65259778 |
| 61 | CDK7 | 0.64792857 |
| 62 | AKT2 | 0.64296176 |
| 63 | RPS6KL1 | 0.62921870 |
| 64 | RPS6KC1 | 0.62921870 |
| 65 | CAMK2D | 0.62837353 |
| 66 | PAK6 | 0.61844467 |
| 67 | TBK1 | 0.60060045 |
| 68 | MAP3K7 | 0.59574256 |
| 69 | MST1R | 0.59444742 |
| 70 | DDR2 | 0.59119097 |
| 71 | PDGFRA | 0.56843563 |
| 72 | MELK | 0.56729932 |
| 73 | ZAP70 | 0.54495868 |
| 74 | RPS6KA6 | 0.53595297 |
| 75 | ROCK1 | 0.53435694 |
| 76 | PIM1 | 0.53388731 |
| 77 | TESK1 | 0.53155710 |
| 78 | CDC7 | 0.51738287 |
| 79 | DAPK3 | 0.50190143 |
| 80 | DAPK2 | 0.49841383 |
| 81 | PRKD1 | 0.48948665 |
| 82 | DYRK1B | 0.48929902 |
| 83 | PRKG2 | 0.48885029 |
| 84 | MAP3K6 | 0.47921600 |
| 85 | PRKAA1 | 0.47591656 |
| 86 | CDK6 | 0.46696537 |
| 87 | CSK | 0.46597474 |
| 88 | AURKB | 0.45327217 |
| 89 | VRK2 | 0.44579496 |
| 90 | MAP3K5 | 0.42960120 |
| 91 | MARK1 | 0.41048932 |
| 92 | STK4 | 0.39929142 |
| 93 | ARAF | 0.39702873 |
| 94 | CDK4 | 0.39104509 |
| 95 | SCYL2 | 0.38562564 |
| 96 | MAPKAPK2 | 0.38225847 |
| 97 | BTK | 0.38220545 |
| 98 | TTK | 0.37988634 |
| 99 | TXK | 0.37910221 |
| 100 | PRKACB | 0.37850236 |
| 101 | PRKG1 | 0.37591617 |
| 102 | ERBB3 | 0.37185710 |
| 103 | CAMK2A | 0.36749347 |
| 104 | MAP3K3 | 0.36589712 |
| 105 | EIF2AK3 | 0.36450530 |
| 106 | MTOR | 0.36301181 |
| 107 | SIK1 | 0.35622029 |
| 108 | PTK2B | 0.34391004 |
| 109 | RPS6KA1 | 0.33845162 |
| 110 | PRKAA2 | 0.33736457 |
| 111 | BRSK2 | 0.32129027 |
| 112 | ROCK2 | 0.30959870 |
| 113 | MAP3K13 | 0.30644930 |
| 114 | CAMK2B | 0.30284277 |
| 115 | CSF1R | 0.30211167 |
| 116 | FLT3 | 0.28636730 |
| 117 | MAPK4 | 0.27684189 |
| 118 | MAP3K8 | 0.26304122 |
| 119 | TGFBR1 | 0.25295065 |
| 120 | PRKD2 | 0.25259494 |
| 121 | CDK19 | 0.24772420 |
| 122 | PAK2 | 0.24600705 |
| 123 | ITK | 0.24408883 |
| 124 | PLK1 | 0.24130035 |
| 125 | PIK3CA | 0.23884636 |
| 126 | AURKA | 0.23157173 |
| 127 | FGFR4 | 0.22423927 |
| 128 | MAP2K4 | 0.22349316 |
| 129 | CDK11A | 0.21801134 |
| 130 | MAPKAPK5 | 0.21443887 |
| 131 | ABL1 | 0.20684613 |
| 132 | PBK | 0.19395006 |
| 133 | PLK2 | 0.18912790 |
| 134 | CDK15 | 0.18311723 |
| 135 | PAK3 | 0.17751436 |
| 136 | MAPK13 | 0.17738608 |
| 137 | MAP2K6 | 0.17028259 |
| 138 | PRKACA | 0.16392339 |
| 139 | RPS6KA3 | 0.15303004 |
| 140 | FER | 0.14483555 |
| 141 | CDK18 | 0.13962297 |
| 142 | CDK14 | 0.13378077 |
| 143 | ABL2 | 0.13134674 |
| 144 | MAPK10 | 0.13059429 |
| 145 | PTK2 | 0.12309646 |
| 146 | TNK2 | 0.11976415 |
| 147 | EIF2AK1 | 0.11544465 |
| 148 | LATS2 | 0.11514991 |
| 149 | PAK1 | 0.11447785 |
| 150 | SGK3 | 0.10952571 |
| 151 | RPS6KB1 | 0.10867508 |
| 152 | CDC42BPA | 0.10811948 |
| 153 | DAPK1 | 0.10788144 |
| 154 | MARK2 | 0.09344692 |
| 155 | CDK9 | 0.08755948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.07159860 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.60269417 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.27193548 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.22172215 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.21980077 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.78184130 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.42433874 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.31866913 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 2.23177819 |
| 10 | Circadian rhythm_Homo sapiens_hsa04710 | 2.20658473 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.14932593 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.01440300 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 1.90274237 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 1.89501438 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.83251753 |
| 16 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.77541124 |
| 17 | Proteasome_Homo sapiens_hsa03050 | 1.69663822 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.65329858 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.63899220 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.53976820 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.52583453 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.52235378 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.51940131 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.45329712 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.43958890 |
| 26 | Tight junction_Homo sapiens_hsa04530 | 1.43227242 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.40369195 |
| 28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.33799193 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.30720531 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.24787843 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.21271709 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.19688608 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15886966 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15514111 |
| 35 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.09179570 |
| 36 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.08685689 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02156027 |
| 38 | RNA transport_Homo sapiens_hsa03013 | 1.01473803 |
| 39 | RNA polymerase_Homo sapiens_hsa03020 | 1.00221403 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99886093 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 0.98378760 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98267609 |
| 43 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.97984858 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94735903 |
| 45 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.94655546 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91386857 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.88969080 |
| 48 | Cell cycle_Homo sapiens_hsa04110 | 0.88781153 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87894592 |
| 50 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86241988 |
| 51 | Leishmaniasis_Homo sapiens_hsa05140 | 0.85745002 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 0.85710784 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85553668 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83772064 |
| 55 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.82748674 |
| 56 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.82130719 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.78819508 |
| 58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.77476514 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.77100714 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.76747337 |
| 61 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.75569075 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.75018118 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74498457 |
| 64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73348322 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72772012 |
| 66 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.72547750 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72039546 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.71587917 |
| 69 | Spliceosome_Homo sapiens_hsa03040 | 0.71077946 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.70597301 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.70258871 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68709262 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68309908 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68255824 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66872595 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63017453 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61323309 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.60959854 |
| 79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60284367 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58918398 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58213328 |
| 82 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58109544 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57579101 |
| 84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.56936874 |
| 85 | Adherens junction_Homo sapiens_hsa04520 | 0.56778376 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56499743 |
| 87 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54487232 |
| 88 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.54304392 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53057458 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53013412 |
| 91 | RNA degradation_Homo sapiens_hsa03018 | 0.52263374 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50866076 |
| 93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50839584 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50146479 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48826245 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.47622829 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47242592 |
| 98 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46491036 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.46108515 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45940879 |
| 101 | Malaria_Homo sapiens_hsa05144 | 0.45819142 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44667989 |
| 103 | Measles_Homo sapiens_hsa05162 | 0.44356232 |
| 104 | Salivary secretion_Homo sapiens_hsa04970 | 0.43916040 |
| 105 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.43796254 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42958591 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42826278 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42455327 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41632476 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.41606660 |
| 111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41539918 |
| 112 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.40951306 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40880776 |
| 114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40409564 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40331508 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39767135 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39135258 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.38167656 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36912410 |
| 120 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.36666063 |
| 121 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.35711336 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35394469 |
| 123 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35379428 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35338238 |
| 125 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35140972 |
| 126 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35069122 |
| 127 | Gap junction_Homo sapiens_hsa04540 | 0.34518217 |
| 128 | Lysine degradation_Homo sapiens_hsa00310 | 0.33750637 |
| 129 | Melanoma_Homo sapiens_hsa05218 | 0.32807204 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32537133 |
| 131 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30680172 |
| 132 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.30104237 |
| 133 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.29483146 |
| 134 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29128270 |
| 135 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.23722345 |
| 136 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.23344179 |
| 137 | Peroxisome_Homo sapiens_hsa04146 | 0.23325530 |
| 138 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.23064427 |
| 139 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.23011230 |
| 140 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20588246 |
| 141 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.18876959 |
| 142 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.18237415 |
| 143 | Glioma_Homo sapiens_hsa05214 | 0.17201968 |
| 144 | Circadian entrainment_Homo sapiens_hsa04713 | 0.14975810 |
| 145 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.13856164 |
| 146 | Purine metabolism_Homo sapiens_hsa00230 | 0.13538125 |
| 147 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.13504876 |
| 148 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.13484913 |
| 149 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.11747598 |
| 150 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.11728232 |
| 151 | Histidine metabolism_Homo sapiens_hsa00340 | 0.11362624 |
| 152 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.08520475 |
| 153 | Endocytosis_Homo sapiens_hsa04144 | 0.08212968 |

